CLINICAL_TRIALS
trial_result
· 2022-08-26
Clinical Trial Update: Extension Study of MYL-1701P-3001 for Safety and Efficacy [Phase 3]
Summary
Extension study results for MYL-1701P-3001 in diabetic macular edema evaluating safety and efficacy after Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mylan Pharmaceuticals Inc | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED